How would you approach a patient with a locoregional recurrence TNBC who requires neoadjuvant treatment?
Patient previously received neoadjuvant carboplatin, anthracycline and taxane regimen and is BRCA negative.
Answer from: Medical Oncologist at Academic Institution
My assumption is that the patient developed this currently unresectable LRR after completing neoadjuvant chemotherapy and surgery, and has to be considered at high risk for both local complications, which is why you want to administer 'neoadjuvant' therapy (although I'm not sure that the term is app...
Sign in or Register to read more